Verrica Pharmaceuticals Statistics Share Statistics Verrica Pharmaceuticals has 9.25M
shares outstanding. The number of shares has increased by 116.77%
in one year.
Shares Outstanding 9.25M Shares Change (YoY) 116.77% Shares Change (QoQ) 0.77% Owned by Institutions (%) 31.07% Shares Floating 5.01M Failed to Deliver (FTD) Shares 33,171 FTD / Avg. Volume 69.2%
Short Selling Information The latest short interest is 2.21M, so 2.39% of the outstanding
shares have been sold short.
Short Interest 2.21M Short % of Shares Out 2.39% Short % of Float 4.31% Short Ratio (days to cover) 2.33
Valuation Ratios The PE ratio is -0.47 and the forward
PE ratio is -2.68.
Verrica Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.47 Forward PE -2.68 PS Ratio 4.79 Forward PS 1.8 PB Ratio -3.68 P/FCF Ratio -0.59 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Verrica Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.76,
with a Debt / Equity ratio of -4.66.
Current Ratio 1.76 Quick Ratio 1.68 Debt / Equity -4.66 Debt / EBITDA -0.7 Debt / FCF -0.75 Interest Coverage -7
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $106.56K Profits Per Employee $-1.08M Employee Count 71 Asset Turnover 0.14 Inventory Turnover 0.75
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -86.79% in the
last 52 weeks. The beta is 1.92, so Verrica Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.92 52-Week Price Change -86.79% 50-Day Moving Average 6.55 200-Day Moving Average 7.16 Relative Strength Index (RSI) 47.28 Average Volume (20 Days) 47,936
Income Statement In the last 12 months, Verrica Pharmaceuticals had revenue of 7.57M
and earned -76.58M
in profits. Earnings per share was -14.8.
Revenue 7.57M Gross Profit 5.71M Operating Income -65.92M Net Income -76.58M EBITDA -65.9M EBIT -67.17M Earnings Per Share (EPS) -14.8
Full Income Statement Balance Sheet The company has 46.33M in cash and 45.94M in
debt, giving a net cash position of 390K.
Cash & Cash Equivalents 46.33M Total Debt 45.94M Net Cash 390K Retained Earnings -307.03M Total Assets 42.18M Working Capital 10.08M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -60.93M
and capital expenditures -27K, giving a free cash flow of -60.95M.
Operating Cash Flow -60.93M Capital Expenditures -27K Free Cash Flow -60.95M FCF Per Share -11.77
Full Cash Flow Statement Margins Gross margin is 75.51%, with operating and profit margins of -871.25% and -1012.15%.
Gross Margin 75.51% Operating Margin -871.25% Pretax Margin -1012.15% Profit Margin -1012.15% EBITDA Margin -870.98% EBIT Margin -871.25% FCF Margin -805.63%
Dividends & Yields VRCA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for VRCA is $60,
which is 788.9% higher than the current price. The consensus rating is "Hold".
Price Target $60 Price Target Difference 788.9% Analyst Consensus Hold Analyst Count 5
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 25, 2025. It was a
backward
split with a ratio of 1:10.
Last Split Date Jul 25, 2025 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -13.96 Piotroski F-Score 4
